Cargando…
The evolution of phase I trials in cancer medicine: a critical review of the last decade
The advent of targeted therapies, combined with an unsustainable rate of failure in oncology drug development, has resulted in a number of new approaches to clinical trials. Early clinical trials are no exception, with efforts to improve the eventual success rate of late stage trials through evolvin...
Autor principal: | Tolcher, Anthony W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013329/ https://www.ncbi.nlm.nih.gov/pubmed/22059910 http://dx.doi.org/10.5732/cjc.011.10133 |
Ejemplares similares
-
The Evolution of Gambling-Related Harm Measurement: Lessons from the Last Decade
por: Browne, Matthew, et al.
Publicado: (2021) -
Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials
por: Rondon, Aurélie, et al.
Publicado: (2021) -
Active SLAM: A Review on Last Decade
por: Ahmed, Muhammad Farhan, et al.
Publicado: (2023) -
Pneumococcal Serotype Evolution and Burden in European Adults in the Last Decade: A Systematic Review
por: Teixeira, Rita, et al.
Publicado: (2023) -
Temperature-to-Digital Converters’ Evolution, Trends and Techniques across the Last Two Decades: A Review
por: Aprile, Antonio, et al.
Publicado: (2022)